clinical trial

NEW COVID-19 CLINICAL TRIAL OF BIOTECH PRODUCT ANNOUNCED TO TREAT PATIENTS WITH UNDERLYING MEDICAL CONDITIONS

East County News Service

 

April 21, 2020 (Pasadena) -- A new clinical trial is being announced today that could significantly increase the rate of recovery for COVID-19 patients with underlying health conditions and save lives. Circularity Healthcares trial will help some of the most at-risk patients suffering from complications due to diabetes, poor circulation, hypertension, cardiovascular disease and high blood pressure. The trial will involve the use of Circularity’s already FDA-approved drug and IDE device D’OXYVA® (deoxyhemoglobin vasodilator) - a non-toxicnon-invasive microcirculation transdermal device. 

 


Error message

Local news in the public interest is more important now than ever, during the COVID-19 crisis. Our reporters, as essential workers, are dedicated to keeping you informed, even though we’ve had to cancel fundraising events. Please give the gift of community journalism by donating at https://www.eastcountymedia.org/donate.